Latest Conference Articles

January 25th 2023, 2:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

January 24th 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

January 23rd 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

January 23rd 2023, 2:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with advanced HCC who progressed after treatment with immunotherapy may have a survival benefit when treated with second-line Lenvima.

January 22nd 2023, 6:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.

January 21st 2023, 7:00pm

ASCO Gastrointestinal Cancers Symposium

Zolbetuximab plus mFOLFOX6 lengthened the time to progression for patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma.

January 20th 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with HER2-low gastric cancer tended to have distinct characteristics compared to those with HER2-negative or -positive disease, warranting more research into this group, research found.

December 18th 2022, 3:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron Gerds and Dr. Andrew Kuykendall answer questions about myelofibrosis during the CURE Educated Patient MPN Summit.

December 17th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Andrew Kuykendall, from the Mofitt Cancer Center, discuss second-line treatments and beyond for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

December 16th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch to Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, discuss frontline treatment options for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

December 15th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Jamile Shammo and Dr. John Mascarenhas answer questions about polycythemia vera during the CURE Educated Patient MPN Summit.

December 14th 2022, 8:00pm

American Society of Hematology Annual Meeting

Progression-free survival and overall response rates greatly improved in patients with CLL/SLL treated with Brukinsa compared with Imbruvica.

December 14th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. John Mascarenhas, from the Icahn School of Medicine at Mount Sinai, discuss future treatments for polycythemia vera, during the CURE Educated Patient MPN Summit.

December 13th 2022, 10:00pm

American Society of Hematology Annual Meeting

Patients with chronic lymphocytic leukemia tended to switch to another regimen or intensify their Calquence treatment quicker than those given Imbruvica, study results showed.

December 13th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Jamile M. Shammo, from Northwestern University Feinberg School of Medicine, discuss current treatment options in polycythemia vera during the CURE Educated Patient MPN Summit.

December 12th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron Gerds and Dr. Douglas Tremblay answer questions about essential thrombocythemia during the CURE Educated Patient MPN Summit.

December 11th 2022, 4:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.

December 10th 2022, 8:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.

December 9th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Francesco Maura, Dr. Marcella Kaddoura and Mary DeRome answer questions about the future of myeloma during the CURE® Educated Patient® Multiple Myeloma Summit.

December 8th 2022, 10:00pm

SABCS

Patients with breast cancer, regardless of their menopausal status, may face worse cognitive ability with chemotherapy and endocrine therapy, although this may return to its pretreatment level after 36 months.

December 8th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Marcella Kaddoura, from Miami Sylvester Comprehensive Cancer Center, discuss targeting myeloma with small molecules with precision medicine during the CURE® Educated Patient® Multiple Myeloma Summit.

December 7th 2022, 2:19pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Francesco Maura, from Miami Sylvester Comprehensive Cancer Center, discuss how personalized prediction models can be used to identify the best treatments during the CURE® Educated Patient Multiple Myeloma Summit.

December 6th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Valarie Traynham, of the HealthTree Foundation, discuss the long-term journey of the disease and disparities still seen during the CURE® Educated Patient® Multiple Myeloma Summit.

December 5th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Dickran Kazandjian and Dr. Benjamin Diamond answer questions about therapeutic options during the CURE® Educated Patient® Multiple Myeloma Summit.

December 4th 2022, 3:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Benjamin T. Diamond, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of sustained MRD negativity during the CURE® Educated Patient® Multiple Myeloma Summit.

December 3rd 2022, 3:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.

December 2nd 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. C. Ola Landgren and Dr. David Coffey answer questions about novel treatments and the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

December 1st 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

November 30th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.

November 29th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.